Stay updated on FIDES-03 Derazantinib Combo in Gastric Adenocarcinoma Clinical Trial

Sign up to get notified when there's something new on the FIDES-03 Derazantinib Combo in Gastric Adenocarcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the FIDES-03 Derazantinib Combo in Gastric Adenocarcinoma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-06T22:38:25.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the usual study record content, signaling that the study page is currently inaccessible.
    Difference
    18%
    Check dated 2026-09-22T23:51:18.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    - The page revision was updated from v3.6.5 to v3.6.6, reflecting a new metadata version of the page.
    Difference
    0.0%
    Check dated 2026-09-01T19:55:28.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    The page shows a new Revision: v3.6.5, replacing the previous v3.6.4. This indicates a minor version update to the page’s documentation or system, with no changes to the study information.
    Difference
    0.0%
    Check dated 2026-08-11T18:30:32.000Z thumbnail image
  7. Check
    87 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.3 to v3.6.4, indicating a minor backend or formatting update without changes to study information.
    Difference
    0.0%
    Check dated 2026-07-21T12:38:25.000Z thumbnail image
  8. Check
    109 days ago
    Change Detected
    Summary
    Revision: v3.6.3 is now shown, replacing the previous v3.6.0. This appears to be a minor maintenance update to the page’s versioning rather than a substantive change to the study information.
    Difference
    0.0%
    Check dated 2026-06-30T00:39:12.000Z thumbnail image

Stay in the know with updates to FIDES-03 Derazantinib Combo in Gastric Adenocarcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the FIDES-03 Derazantinib Combo in Gastric Adenocarcinoma Clinical Trial page.